Cargando…
β-elemene enhances cisplatin-induced apoptosis in bladder cancer cells through the ROS-AMPK signaling pathway
Cisplatin-based chemotherapy is the standard regimen for patients with bladder cancer, but its effectiveness is limited by high toxicity and the development of drug resistance. β-elemene (β-ELE), a compound extracted from Rhizoma zedoariae, has antitumor activity in various malignancies and exhibits...
Autores principales: | Gan, Daoju, He, Weiyang, Yin, Hubin, Gou, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924103/ https://www.ncbi.nlm.nih.gov/pubmed/31897141 http://dx.doi.org/10.3892/ol.2019.11103 |
Ejemplares similares
-
Identification of a 13-mRNA signature for predicting disease progression and prognosis in patients with bladder cancer
por: Yin, Hubin, et al.
Publicado: (2020) -
β-Elemene Triggers ROS-dependent Apoptosis in Glioblastoma Cells Through Suppressing STAT3 Signaling Pathway
por: Cai, Shi-zhong, et al.
Publicado: (2021) -
β-elemene enhances the antitumor activity of erlotinib by inducing apoptosis through AMPK and MAPK pathways in TKI-resistant H1975 lung cancer cells
por: Wang, Jue, et al.
Publicado: (2021) -
An ATF(24) peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment
por: Zhai, Bingtao, et al.
Publicado: (2020) -
Nucleolar and Spindle Associated Protein 1 (NUSAP1) Promotes Bladder Cancer Progression Through the TGF-β Signaling Pathway
por: Gao, Shun, et al.
Publicado: (2020)